|
2024
|
Invention
|
Articles of manufacture and methods for treatment using adoptive cell therapy.
Provided are adop... |
|
|
Invention
|
Aav purification method. Provided herein are methods for obtaining an AAV full capsid from an AAV... |
|
|
Invention
|
Methods of assessing or monitoring a response to a cell therapy.
Provided are methods and articl... |
|
|
Invention
|
Activation markers of t cells and method for assessing t cell activation. The present disclosure ... |
|
|
Invention
|
Methods for viral vector manufacturing. Provided herein are methods for developing a lentiviral v... |
|
|
Invention
|
Cytotoxicity assay for assessing potency of therapeutic cell compositions. The present disclosure... |
|
|
Invention
|
Methods and compositions for preparing genetically engineered cells.
Provided are methods for pr... |
|
|
Invention
|
Cell therapy for treating systemic autoimmune diseases. Provided herein are adoptive cell therapy... |
|
|
Invention
|
Cell therapy for treating systemic autoimmune diseases.
Provided herein are adoptive cell therap... |
|
2023
|
Invention
|
Chimeric antigen receptors specific for baff-r and cd19 and methods and uses thereof.
Provided a... |
|
|
Invention
|
Chimeric antigen receptors specific for baff-r and cd19 and methods and uses thereof. Provided ar... |
|
|
Invention
|
Machine learning methods for predicting cell phenotype using holographic imaging. Provided herein... |
|
|
Invention
|
Methods for producing genetically engineered cell compositions and related compositions.
Provide... |
|
|
Invention
|
Method of assessing activity of recombinant antigen receptors.
Provided herein are methods for s... |
|
|
Invention
|
Methods and compositions for adoptive cell therapy.
Provided are methods for multiple administra... |
|
|
P/S
|
Medical preparations for the treatment of cancer and autoimmune diseases; pharmaceutical and medi... |
|
|
Invention
|
Epigenetic analysis of cell therapy and related methods.
Provided herein are methods of identify... |
|
|
P/S
|
Pharmaceutical and medical preparations in the nature of medical preparations for the treatment o... |
|
|
Invention
|
Methods and compositions related to toxicity associated with cell therapy.
Provided are methods,... |
|
|
Invention
|
Methods for transduction and cell processing.
Provided are methods, systems, and kits for cell p... |
|
|
Invention
|
Methods for assessing cell surface glycosylation.
Provided herein are methods for assessing cell... |
|
|
Invention
|
Combination of a t cell therapy and continuous or intermittent dgk inhibitor dosing. Provided her... |
|
|
Invention
|
Antibodies and chimeric antigen receptors specific for delta-like ligand 3 (dll3). Provided are D... |
|
|
Invention
|
Chimeric antigen receptors specific for gprc5d and bcma.
Provided are chimeric antigen receptors... |
|
|
Invention
|
Chimeric antigen receptors specific for gprc5d and bcma. Provided are chimeric antigen receptors ... |
|
|
Invention
|
Articles of manufacture and methods related to toxicity associated with cell therapy.
Provided a... |
|
|
Invention
|
Antibodies and chimeric antigen receptors specific for cd19.
Provided are CD19 binding molecules... |
|
|
Invention
|
Lipid nanoparticles for delivery of nucleic acids. The present disclosure relates to compositions... |
|
|
Invention
|
Treatment methods for second line therapy of cd19-targeted car t cells. Provided are adoptive cel... |
|
|
P/S
|
Clinical preparations in the nature of chemical, biological, and cellular preparations for use in... |
|
|
Invention
|
Antibodies and chimeric antigen receptors specific for b-cell maturation antigen.
Provided herei... |
|
|
Invention
|
Detection assay for human papillomavirus (hpv) type 16 (hpv-16). Provided herein is a method of d... |
|
|
Invention
|
Methods and compositions for dosing in adoptive cell therapy.
Provided are methods for administe... |
|
|
Invention
|
Proteinase 3 (pr3) chimeric autoantibody receptor t cells and related methods and uses. Provided ... |
|
|
Invention
|
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptiv... |
|
|
Invention
|
Methods of manufacturing cellular compositions. Provided are methods of continuous counterflow ce... |
|
|
Invention
|
Chromatography arrays and related methods and kits. Provided herein are chromatography arrays for... |
|
|
Invention
|
Methods and compositions for use of therapeutic t cells in combination with kinase inhibitors.
T... |
|
2022
|
Invention
|
Methods and reagents for assessing the presence or absence of replication competent virus.
Provi... |
|
|
Invention
|
T cell receptors and engineered cells expressing same.
Provided herein are binding molecules, su... |
|
|
Invention
|
Combination of a car t cell therapy and an immunomodulatory compound for treatment of lymphoma.
... |
|
|
Invention
|
Methods for dosing and treatment with a combination of a checkpoint inhibitor therapy and a car t... |
|
|
Invention
|
Methods of determining potency of a therapeutic cell composition.
The present disclosure relates... |
|
|
Invention
|
Combination of a t cell therapy and a dgk inhibitor.
Provided herein are methods, compositions a... |
|
2021
|
Invention
|
Threshold gating for flow cytometry methods.
Provided are methods for flow cytometry analysis, i... |
|
|
Invention
|
Cells expressing a chimeric receptor from a modified invariant cd3 immunoglobulin superfamily cha... |
|
|
Invention
|
Car t cell therapy in patients who have had prior anti-cancer alkylator therapy.
Provided herein... |
|
|
Invention
|
Anti-idiotypic antibodies to ror1-targeted binding domains and related compositions and methods. ... |
|
|
P/S
|
Collection and preservation of human biological tissue, blood and cells; medical diagnostic servi... |
|
|
Invention
|
Cd19-directed chimeric antigen receptor t cell compositions and methods and uses thereof.
Provid... |
|
2020
|
Invention
|
Anti-idiotypic antibodies to gprc5d-targeted binding domains and related compositions and methods... |
|
|
P/S
|
Pharmaceutical preparations for human use Medical services |
|
|
P/S
|
Medical treatment of cancer, lymphoma; provision of information and data for diagnosis and medica... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer and
auto-immune diseases; pharmaceutical... |
|
2019
|
P/S
|
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the trea... |
|
2018
|
P/S
|
Pharmaceutical preparations for the treatment of cancer [ and auto-immune diseases ] ; pharmaceut... |
|
|
Invention
|
Reagents for expanding cells expressing recombinant receptors.
The present disclosure provides c... |
|
2017
|
P/S
|
Pharmaceuticals for the treatment of cancer and auto-immune diseases; pharmaceutical preparations... |
|
|
Invention
|
Anti-idiotypic antibodies against anti-cd19 antibodies.
Provided herein are anti-idiotype antibo... |
|
2016
|
P/S
|
Eukaryotic cells for medical and clinical use; Human T Cells and B Cells for medical and clinical... |
|
|
P/S
|
Cells for medical or clinical use; kits comprised of cells and pharmaceuticals for medical or cli... |
|
|
P/S
|
Cells for medical or clinical use; kits comprised of cells
and pharmaceuticals for medical or cl... |
|
|
P/S
|
Computer software, in particular relating to health care; Apps, namely software applications for ... |
|
|
P/S
|
Scientific laboratory services, namely, processing blood to isolate lymphocytes for the creation ... |
|
2015
|
P/S
|
Chemical reagents for the stimulation and/or expansion of
cells, in particular of cells of the i... |
|
2014
|
P/S
|
Pharmaceutical preparations for the treatment of cancer; pharmaceutical and veterinary preparatio... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer. Business services, namely, commercializa... |
